MedTrace Logo

Exercise Dose-response for Diabetes in the Elderly

NCT03423108 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 132

Last updated 2018-09-06

No results posted yet for this study

Summary

One-center randomized, three-arm, parallel, superiority, controlled trial in 132 elderly outpatients with type 2 diabetes. Two different combined exercise training doses (300min/week vs 150min/week) will be compared against usual care. The entire study length will last 24 weeks, and assessments will be conducted at baseline, previously to the group allocation, at 12 weeks and at 24 weeks just after the treatments' end. The study's primary outcome is the glycated hemoglobin level at 24 weeks. Secondary outcomes of clinical relevance to type 2 diabetes and elderlies will also be acquired.

Conditions

  • Type2 Diabetes

Interventions

BEHAVIORAL

G150

This group will receive 150 min/week of combined exercise training, structured and supervised.

BEHAVIORAL

G300

This group will receive 300 min/week of combined exercise training, structured and supervised.

Sponsors & Collaborators

  • Federal University of Rio Grande do Sul

    collaborator OTHER

  • Hospital de Clinicas de Porto Alegre

    lead OTHER

Principal Investigators

  • Daniel Umpierre, PhD · Hospital de Clinicas de Porto Alegre/Federal University of Rio Grande do Sul

  • Beatriz Schaan, MD, PhD · Hospital de Clinicas de Porto Alegre/Federal University of Rio Grande do Sul

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-09-10
Primary Completion
2019-01-01
Completion
2020-08-01

Countries

  • Brazil

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03423108 on ClinicalTrials.gov